Cargando…

Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo

The functional inactivation of TP53 and Rb tumor suppressor proteins by the HPV-derived E6 and E7 oncoproteins is likely an important step in cervical carcinogenesis. We have previously shown siRNA technology to selectively silence both E6/E7 oncogenes and demonstrated that the synthetic siRNAs coul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Hun Soon, Rajasekaran, Nirmal, Song, Sang Yong, Kim, Young Deug, Hong, Sungyoul, Choi, Hyuck Jae, Kim, Young Seok, Choi, Jong-Sun, Choi, Yoon-La, Shin, Young Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490442/ https://www.ncbi.nlm.nih.gov/pubmed/26035754 http://dx.doi.org/10.3390/ijms160612243

Ejemplares similares

Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions
por: Rajasekaran, Nirmal, et al.
Publicado: (2017)

Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer
por: Jung, Hun Soon, et al.
Publicado: (2015)

Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer
por: Jayamohan, Sridharan, et al.
Publicado: (2019)

Corrigendum: Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer
por: Jayamohan, Sridharan, et al.
Publicado: (2021)

Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting
por: Yang, Hobin, et al.
Publicado: (2019)

A Glycoengineered Interferon-β Mutein (R27T) Generates Prolonged Signaling by an Altered Receptor-Binding Kinetics
por: Lee, Saehyung, et al.
Publicado: (2019)

O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes
por: Kim, Minjun, et al.
Publicado: (2016)

AsiDesigner: exon-based siRNA design server considering alternative splicing
por: Park, Young-Kyu, et al.
Publicado: (2008)

Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer
por: D. S., Prabakaran, et al.
Publicado: (2022)

Recent Developments in Nanoparticle-Based siRNA Delivery for Cancer Therapy
por: Lee, Jong-Min, et al.
Publicado: (2013)

Left Ventricular Filling Pressure as Assessed by the E/e' Ratio Is a Determinant of Atrial Fibrillation Recurrence after Cardioversion
por: Chung, Hyemoon, et al.
Publicado: (2016)

Expression data of HeLa cells treated with CENP-E siRNA or Eg5 siRNA in the presence of BubR1 siRNA
por: Nakayama, Yusuke, et al.
Publicado: (2015)

Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo
por: Jang, Ji-Young, et al.
Publicado: (2008)

Attenuated Nuclear Factor Kappa B Activity by E7 Protein of Human Papillomavirus Type 2 in Human Epidermal Keratinocytes
por: Ryu, Yun Hee, et al.
Publicado: (2017)

Self-Assembling β-Glucan Nanomedicine for the Delivery of siRNA
por: Lee, Kyungwoo, et al.
Publicado: (2020)

Design of siRNA Bioconjugates for Efficient Control of Cancer-Associated Membrane Receptors
por: Lee, Jong Won, et al.
Publicado: (2023)

Epigallocatechin-3-gallate Can Prevent Type 2 Human Papillomavirus E7 from Suppressing Interferon-Stimulated Genes
por: Song, Ji Young, et al.
Publicado: (2021)

Physical Status of Human Papillomavirus Integration in Cervical Cancer Is Associated with Treatment Outcome of the Patients Treated with Radiotherapy
por: Shin, Hye-Jin, et al.
Publicado: (2014)

Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers
por: Chang, J T-C, et al.
Publicado: (2010)

Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer
por: Lee, Yoo-Young, et al.
Publicado: (2019)

Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells
por: Hong, D, et al.
Publicado: (2009)

Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease
por: Shinn, Jongyoon, et al.
Publicado: (2022)

Cervical Cancer Screening and Human Papillomavirus Vaccination among Korean Sexual Minority Women by Sex of Their Sexual Partners
por: Kim, Ssirai, et al.
Publicado: (2020)

Utility of MicroRNAs and siRNAs in Cervical Carcinogenesis
por: Díaz-González, Sacnite del Mar, et al.
Publicado: (2015)

Enhanced Cell Growth of Adipocyte-Derived Mesenchymal Stem Cells Using Chemically-Defined Serum-Free Media
por: Lee, Myung-Suk, et al.
Publicado: (2017)

MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer
por: Han, Jinil, et al.
Publicado: (2017)

New Preclinical Development of a c-Met Inhibitor and Its Combined Anti-Tumor Effect in c-Met-Amplified NSCLC
por: Kim, Nam Ah, et al.
Publicado: (2020)

Human CD64-targeted non-viral siRNA delivery system for blood monocyte gene modulation
por: Yong, Seok-Beom, et al.
Publicado: (2017)

Targeting HPV‐infected cervical cancer cells with PEGylated liposomes encapsulating siRNA and the role of siRNA complexation with polyethylenimine
por: Levine, Rachel M., et al.
Publicado: (2016)

Usefulness of the human papillomavirus DNA chip test as a complementary method for cervical cytology
por: Lee, Rae-Young, et al.
Publicado: (2023)

SMAD4 Controls Cancer Cell Metabolism by Regulating Methylmalonic Aciduria Cobalamin Deficiency (cbl) B Type
por: Song, Kyoung, et al.
Publicado: (2022)

MGMT Methylation Is Associated with Human Papillomavirus Infection in Cervical Dysplasia: A Longitudinal Study
por: Choi, Boram, et al.
Publicado: (2023)

The Transition from Primary siRNAs to Amplified Secondary siRNAs That Regulate Chalcone Synthase During Development of Glycine max Seed Coats
por: Cho, Young B., et al.
Publicado: (2013)

Tetrazine-Induced Bioorthogonal Activation of Vitamin E-Modified siRNA for Gene Silencing
por: Zhang, Xueli, et al.
Publicado: (2022)

Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy
por: Xu, Cong, et al.
Publicado: (2020)

Attenuated Salmonella carrying plasmid co-expressing HPV16 L1 and siRNA-E6 for cervical cancer therapy
por: Chen, Junyu, et al.
Publicado: (2021)

Efficacy of Asymmetric siRNA Targeting Androgen Receptors for the Treatment of Androgenetic Alopecia
por: Moon, Ik Jun, et al.
Publicado: (2022)

Physiological activity of E. coli engineered to produce butyric acid
por: Park, Young‐Tae, et al.
Publicado: (2021)

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
por: Pal, Asmita, et al.
Publicado: (2020)

siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model
por: Jung, Jae Yun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o38i4n85iikd2go7ifnvhs9i6g